Proton pump inhibitor use ups pneumonia risk in dementia

Proton pump inhibitor use ups pneumonia risk in dementia

(HealthDay)—For patients with dementia, proton pump inhibitor (PPI) use is associated with increased risk of pneumonia, according to a study published online March 21 in the Journal of the American Geriatrics Society.

Sai-Wai Ho, M.D., from the Chung Shan Medical University in Taichung, China, and colleagues conducted a involving 786 patients with dementia with new PPI usage and 786 matched patients with dementia without PPI usage.

The researchers found that patients with PPI usage had higher incidence of pneumonia (adjusted hazard ratio, 1.89). Independent risk factors for pneumonia included age, male gender, underlying cerebrovascular disease, chronic pulmonary disease, congestive heart failure, diabetes mellitus, and antipsychotic use (adjusted hazard ratios, 1.05, 1.57, 1.30, 1.39, 1.54, 1.54, and 1.29, respectively). Pneumonia risk was decreased with usage of cholinesterase inhibitors and histamine receptor-2 antagonists.

"PPI usage in dementia patients is associated with an 89 percent increased risk of ," the authors write.


Explore further

Colonic diverticular disease may increase dementia risk

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: Proton pump inhibitor use ups pneumonia risk in dementia (2017, March 30) retrieved 23 July 2019 from https://medicalxpress.com/news/2017-03-proton-inhibitor-ups-pneumonia-dementia.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more